Le Lézard
Classified in: Health, Business
Subjects: CON, VET

MellingMedical Renews and Expands Federal Supply Schedule


Provides pathway for cutting edge medical equipment delivering care for America's veterans

ALEXANDRIA, Va., Aug. 18, 2022 /PRNewswire/ -- MellingMedical is honored to announce the renewal and expansion of its Federal Supply Schedule contract that several of America's top medical device and equipment companies have leveraged to deliver resources across Veterans Affairs, DoD, and other federal medical facilities.

MellingMedical is honored to announce the renewal and expansion of its Federal Supply Schedule (FSS) contract.

"As a company founded and led by military veterans, we are especially proud to play a role in delivering state-of-the-art medical equipment and supplies to patients receiving care from the Veterans Administration," said Chris Melling, founder and CEO of MellingMedical. "The roster of companies on our supply schedule that have trusted us to support their federal health system sales is an affirmation of our ethical approach to business and our track record of successfully navigating the federal acquisition system for our manufacturing partners."

MellingMedical's new five-year Federal Supply Schedule (FSS) Contract (36F79722D01891) is effective August 15, 2022, through August 14, 2027, with five additional option years. The items are awarded under Schedule 65 II A - Medical Equipment and Supplies under Federal Supply Schedule Solicitation RFP-797-FSS-99-0025-R10. The contract replaces Melling's expiring Medical Surgical Federal Supply Schedule (Contract No V797D-50471).

Under GSA-delegated authority, the VA manages multiple award contracts for medical equipment, supply, pharmaceutical, and service Schedule programs.  With over $14 billion in sales, the VA FSS Service supports the healthcare requirements of the VA and other federal government agencies by providing Federal customers access to more than 1 million state-of-the-art commercial products and services.

Multiple manufacturing suppliers included on MellingMedical's original schedule have products listed on the renewal contract, including:

In addition, MellingMedical has added products supplied by the below companies in the renewal contract:

About MellingMedical

MellingMedical, a CVE-Verified Service-Disabled Veteran-Owned Small Business (SDVOSB), holds a Medical Equipment and Surgical Federal Supply Schedule (Med/Surg), as well as a Pharmaceutical Schedule, and currently serves more than 165 VA Medical Centers and 300 VA Outpatient clinics, all seven (7) VA CMOPs, 95 DoD Medical Facilities and Health and Human Services (HHS), including Indian Health Services (IHS) and the Center for Disease Control (CDC). MellingMedical provides access to innovative and cost-effective healthcare solutions in ophthalmology, optometry, urology and wound care. To learn more, visit MellingMedical.com.

SOURCE MellingMedical


These press releases may also interest you

at 18:56
Hike Doggie, the premier dog hiking service dedicated to enriching the lives of dogs and their parents through adventure and companionship, is thrilled to announce the opening of its first franchise location servicing the Denver South area. This...

at 18:53
Live! Gaming & Entertainment District, Anchored by Live! Casino & Hotel Virginia, Will Set a New Standard for Development in the Commonwealth, Create Thousands of Jobs, Increase Tourism and Generate Billions in Economic Benefits Plans for the Project...

at 18:46
MAV Capital is an alternative asset manager focused on agribusiness with approximately R$550 million in assets under management in sector specific private credit funds, led by a best-in-class and highly seasoned team with extensive experience in the...

at 18:38
Clearview Resources Ltd. ("Clearview" or the "Company") is pleased to announce its reserves report and financial and operational results for the year ended December 31, 2023....

at 18:24
The scheduled merits hearing dates, April 26 and 29, 2024, in the above-named matter will proceed by videoconference. On April 26, 2024, the hearing will commence 11:15 a.m. Members of the public may observe the hearing by videoconference, by...

at 18:15
Consolidated Financial Highlights (unaudited) (in thousands of dollars except per shareamounts)Three months endedMarch 31,2024March 31,2023Net loss(701)(8,051)Basic and diluted loss per share(0.03)(0.33) Operating Data  Three months...



News published on and distributed by: